Discontinuation report (20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE INJECTION USP
Report ID | 257296 |
Drug Identification Number | 00438049 |
Brand name | (20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE INJECTION USP |
Common or Proper name | test |
Company Name | BAXTER CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | POTASSIUM CHLORIDE DEXTROSE |
Strength(s) | 150MG 5G |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | test |
ATC code | B05BB |
ATC description | I.V. SOLUTIONS |
Reason for discontinuation | Raw material availability |
Anticipated discontinuation date | 2024-03-05 |
Actual discontinuation date | |
Remaining supply date | 2024-04-04 |
Discontinuation status | To be discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2025-09-03 | French | Compare |
v3 | 2025-09-03 | English | Compare |
v2 | 2025-09-03 | English | Compare |
v1 | 2025-09-03 | English | Compare |
Showing 1 to 4 of 4